Turnaround

Tilray Brands, Inc. has achieved a significant financial milestone, reporting its first quarterly net profit after years of sustained losses....

Despite posting robust quarterly earnings and initiating a substantial share repurchase plan, Morningstar's stock continues to struggle with significant price...

The future of Kezar Life Sciences hangs in the balance following a devastating regulatory development that has forced the biotechnology...

The pharmaceutical firm Organon & Co. is confronting its most severe corporate challenge to date following the discovery of manipulated...

Semler Scientific finds itself navigating treacherous waters as a potential rescue acquisition and substantial Bitcoin holdings fail to stem mounting...

Pharmaceutical giant Bristol-Myers Squibb has demonstrated a remarkable turnaround, with its latest quarterly report exceeding investor expectations through unexpectedly robust...

PDS Biotechnology Corp has taken a decisive step in its regulatory strategy, potentially altering the trajectory for its lead immunotherapy...

The global logistics leader has jolted financial markets with quarterly results that demolished Wall Street's projections. While the broader shipping...

Chinese electric vehicle manufacturer BYD is confronting significant financial challenges, marked by a sharp decline in quarterly profits and the...

In a bold strategic pivot, UnitedHealth Group is deliberately planning to reduce its Medicare Advantage membership by approximately one million...